Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Theratechnologies and EMD Serono sign licensing agreement for tesamorelin

Dec. 22, 2008

Tibotec initiates recruitment in phase III trials of NNRTI drug TMC-278 for HIV

Dec. 22, 2008

Theratechnologies reports results from phase III clinical trial of tesamorelin

Dec. 19, 2008

FDA accepts for review Merck & Co.'s sNDA for Isentress for treatment-naive HIV-1 patients

Dec. 18, 2008

Panacos presents update on HIV drug pipeline

Dec. 17, 2008

Prezista receives expanded E.U. MA for treatment-experienced HIV patients

Dec. 10, 2008

HIV candidate VCH-286 safe, well tolerated in phase I study

Dec. 4, 2008

GeoVax commences phase IIa HIV/AIDS vaccine human trials

Dec. 3, 2008

FDA grants full approval to Pfizer's CCR5 antagonist Selzentry for HIV

Nov. 28, 2008

CHMP recommends extension to Janssen-Cilag's marketing authorization for Prezista

Nov. 26, 2008

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026